BDBM725032 3-(tert-butyl)-N-(4-(2- (cyclopropanecarboxamido) pyridin-4-yl)-2-cyclopropyl- 3-fluorobenzyl)-1,2,4- oxadiazole-5-carboxamide::US12240838, Compound 34

SMILES CC(C)(C)c1noc(C(=O)NCc2ccc(-c3ccnc(NC(=O)C4CC4)c3)c(F)c2C2CC2)n1

InChI Key InChIKey=BSSWVEQFDVFATD-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 725032   

TargetTyrosine-protein kinase BTK(Human)
Biogen Ma

US Patent
LigandPNGBDBM725032(3-(tert-butyl)-N-(4-(2- (cyclopropanecarboxamido) ...)
Affinity DataIC50: 1nMAssay Description:The purpose of the BTK in vitro assay is to determine compound potency against BTK through the measurement of IC50. Compound inhibition is measured a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/6/2025
Entry Details
Go to US Patent